Effectiveness and safety of ranibizumab 0.5 mg in treatment-naïve patients with diabetic macular edema: Results from the real-world global LUMINOUS study

PURPOSE: To assess the one-year effectiveness and safety of ranibizumab 0.5 mg in treatment- naïve patients with diabetic macular edema (DME) enrolled in the real-world LUMINOUS study. PATIENTS AND METHODS: A 5-year, prospective, observational, open-label, global study which recruited 30,138 patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Mitchell, Paul, Sheidow, Tom G., Farah, Michel E., Mahmood, Sajjad, Minnella, Angelo M., Eter, Nicole, Eldem, Bora, Al-Dhibi, Hassan, Macfadden, Wayne, Parikh, Soumil, Dunger-Baldauf, Cornelia, Mahgoub, Mohamed M., Schmidt-Erfurth, Ursula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7269267/
https://www.ncbi.nlm.nih.gov/pubmed/32492069
http://dx.doi.org/10.1371/journal.pone.0233595

Ejemplares similares

Ejemplares similares